Profiel
Matthew J.
Pietras worked as the Chief Operating & Financial Officer at StageZero Life Sciences Ltd. in 2021-2022.
Prior to that, he was the Treasurer & Controller at Viela Bio, Inc. from 2017-2019.
He also worked as the Vice President-Finance at CiVi Biopharma, Inc. His education includes an MBA from The Johns Hopkins University and an undergraduate degree from The Pennsylvania State University.
Eerdere bekende functies van Matthew J. Pietras
| Bedrijven | Functie | Einde |
|---|---|---|
| STAGEZERO LIFE SCIENCES LTD. | Financieel Directeur/CFO | 26-05-2022 |
| VIELA BIO, INC. | Comptroller/Controller/Auditor | 01-01-2019 |
CiVi Biopharma, Inc.
CiVi Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which manufactures novel therapies against cardiovascular and metabolic diseases | Financieel Directeur/CFO | - |
Opleiding van Matthew J. Pietras
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
StageZero Life Sciences Ltd.
StageZero Life Sciences Ltd. Medical SpecialtiesHealth Technology Operates as a cancer diagnostics company | Health Technology |
CiVi Biopharma, Inc.
CiVi Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which manufactures novel therapies against cardiovascular and metabolic diseases | Health Technology |
Viela Bio, Inc.
Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
















